Genomic Health's Q1 Revenues Rise 2 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its first quarter revenues were up two percent year over year, driven by increased sales for its Oncotype DX tests.

The Redwood City, California-based molecular diagnostics firm brought in total revenues of $68.2 million for the three months ended March 31, up from $67 million in the first quarter of 2014 but below the consensus Wall Street estimate of $69.9 million. All of its revenue in the quarter came from product sales.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.